Cardiorespiratory fitness linked with decreased metabolic syndrome risk among smokers
the ONA take:
According to a new study published in the American Journal of Preventive Medicine, researchers from The University of Texas Health Science Center at Houston School of Public Health in Houston, Texas, have found that cardiorespiratory fitness is associated with a decreased risk of metabolic syndrome among smokers.
For the study, researchers analyzed data from 1,249 adult smokers who participated in the Cooper Center Longitudinal Study between 1979 and 2011.
Results showed that smokers with the highest level of cardiopulmonary fitness had a 48% decreased risk of metabolic syndrome compared with those with lowest level of fitness. Those who did moderate fitness had a 27% lower risk versus those who had low fitness levels.
"Study findings indicate that there is an inverse relationship between cardiorespiratory fitness and cardiometabolic risk among adult smokers" said Darla Kendzor, Ph.D., assistant professor in the Department of Health Promotion and Behavioral Sciences at UTHealth School of Public Health Dallas Regional Campus.
Although the findings show that fitness is beneficial among smokers, the authors stress the importance of smoking cessation to decrease overall morbidity and mortality.
Cardiorespiratory fitness is associated with a decreased risk of metabolic syndrome among smokers.
Sign Up for Free e-newsletters
- Chemotherapy-Related Fatigue Linked to Levothyroxine Use in Breast Cancer
- New Hypertension Threshold Guides Blood Pressure Management During Cancer Treatment
- Sexual Aids and Resources Not Readily Available at Cancer Centers
- Gas Mixture Improves Efficacy of Breakthrough Cancer Pain Treatment
- Factors Affecting Employment Participation in Early-stage Breast Cancer
- Sitting With Silence in End-of-Life Cancer Care
- Obesity and Cancer Risk (Fact Sheet)
- Susceptibility Gene Mutations Common in Those With Pancreatic Cancer and History of Other Cancers
- Anticancer Properties of Omega-3 Fatty Acids: Plant-Based vs Marine-Based
- US Pharmacopeia Revises Chapter on Handling Hazardous Drugs
- Adjuvant Vemurafenib Does Not Improve Disease-Free Survival in Melanoma
- Profile of Buparlisib and its Potential in the Treatment of Breast Cancer: Evidence to Date
- Exercise Before Lung Cancer Surgery Greatly Reduces Complications
- Hodgkin Lymphoma Treatment in EU vs US: Similarities Would Enable Worldwide Studies
- Zinc Sulfate Improves Chemotherapy-Induced Mucositis Outcomes in Leukemia
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|